Yüklüyor......
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has gi...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3316959/ https://ncbi.nlm.nih.gov/pubmed/22530130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/327253 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|